THE CLINICAL AND MOLECULAR EFFECTS OF AN INSULIN SENSITIZING DRUG ‘PIOGLITAZONE’ ON TREATMENT OF PSORIASIS
Vanessa Suzan Galal Aly Hafez;
Abstract
SUMMARY
Psoriasis is a common chronic inflammatory disease that causes a significant impact on patient's quality of life. Its prevalence is estimated to reach up to 4.8% of the population according to the regions. Psoriasis is considered moderate to sever
Psoriasis is a common chronic inflammatory disease that causes a significant impact on patient's quality of life. Its prevalence is estimated to reach up to 4.8% of the population according to the regions. Psoriasis is considered moderate to sever
Other data
| Title | THE CLINICAL AND MOLECULAR EFFECTS OF AN INSULIN SENSITIZING DRUG ‘PIOGLITAZONE’ ON TREATMENT OF PSORIASIS | Other Titles | المفعول الإكلينيكي والجزيئي للدواء المحسس للانسولين "بيوجليتازون" في علاج الصدفية | Authors | Vanessa Suzan Galal Aly Hafez | Keywords | THE CLINICAL AND MOLECULAR EFFECTS OF AN INSULIN SENSITIZING DRUG ‘PIOGLITAZONE’ ON TREATMENT OF PSORIASIS | Issue Date | 2011 | Description | SUMMARY Psoriasis is a common chronic inflammatory disease that causes a significant impact on patient's quality of life. Its prevalence is estimated to reach up to 4.8% of the population according to the regions. Psoriasis is considered moderate to sever |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.